Literature DB >> 16607796

The morphologic changes induced by hormone and radiation therapy on prostate carcinoma.

Silvia Lăcrămioara Roznovanu1, Doiniţa Rădulescu, C Novac, Simona Stolnicu.   

Abstract

The morphologic changes induced by hormone and radiation therapy were evaluated in prostate biopsy and prostatectomy specimens from patients with residual prostate carcinoma. The two therapeutic methods induce changes both in the nonmalignant and malignant residual prostatic tissue. Following hormone therapy, the nonmalignant prostatic tissue showed atrophy of prostatic acini associated with fibrosis, basal cell hyperplasia, degenerative changes of the secretory epithelial cells, and a marked decrease of high-grade intraepithelial neoplasia (HGPIN). In the fragments of residual carcinoma, squamous cell metaplasia, necrosis, and necrobiosis in the foci, vacuolization of the cell cytoplasm, smaller, rare nucleoli, intraluminal crystalloids, higher Gleason score associated with a lower capsular penetration, areas of necrosis and mitoses were found. Following radiation therapy, the nontumoral prostatic tissue showed an increased number of atrophic acini, squamous cell metaplasia, and presence of atypical glands. The morphologic changes induced by radiation therapy in the residual prostatic carcinoma were characterized by an abnormal architectural structure of the glands and presence of cell atypias correlated with the biochemical lowering of serum PSA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16607796

Source DB:  PubMed          Journal:  Rev Med Chir Soc Med Nat Iasi        ISSN: 0048-7848


  9 in total

1.  Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer.

Authors:  L Liu; N Wu; H Ouyang; J-R Dai; W-H Wang
Journal:  Br J Radiol       Date:  2014-08-27       Impact factor: 3.039

2.  PI-RADS score v.2 in predicting malignancy in patients undergoing 5α-reductase inhibitor therapy.

Authors:  V Forte; A U Cavallo; R Bertolo; V de Soccio; M Sperandio; P Bove; M Ciccariello
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-07-17       Impact factor: 5.554

3.  Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone.

Authors:  Hidekazu Tanaka; Takahiro Yamaguchi; Kae Hachiya; Masahide Hayashi; Shinichi Ogawa; Hironori Nishibori; Shingo Kamei; Satoshi Ishihara; Masayuki Matsuo
Journal:  Rep Pract Oncol Radiother       Date:  2017-09-19

Review 4.  Prostatic fibrosis, lower urinary tract symptoms, and BPH.

Authors:  Jose A Rodriguez-Nieves; Jill A Macoska
Journal:  Nat Rev Urol       Date:  2013-07-16       Impact factor: 14.432

5.  Changes in prostate apparent diffusion coefficient values during radiotherapy after neoadjuvant hormones.

Authors:  Andrew McPartlin; Lucy Kershaw; Alan McWilliam; Marcus Ben Taylor; Clare Hodgson; Marcel van Herk; Ananya Choudhury
Journal:  Ther Adv Urol       Date:  2018-10-11

6.  Imbalance in the estrogen/androgen ratio may affect prostate fibrosis through the TGF-β/Smad signaling pathway.

Authors:  Ying Cao; Ye Tian; Heng Zhang; Guang-Heng Luo; Zhao-Lin Sun; Shu-Jie Xia
Journal:  Int Urol Nephrol       Date:  2022-01-20       Impact factor: 2.370

7.  Histological changes caused by meclofenamic acid in androgen-independent prostate cancer tumors: evaluation in a mouse model.

Authors:  Iván Delgado-Enciso; Alejandro D Soriano-Hernández; Alejandrina Rodriguez-Hernandez; Héctor R Galvan-Salazar; Daniel A Montes-Galindo; Rafael Martinez-Martinez; Laura L Valdez-Velazquez; Rafael Gonzalez-Alvarez; Francisco Espinoza-Gómez; Oscar A Newton-Sanchez; Agustín Lara-Esqueda; Jose Guzman-Esquivel
Journal:  Int Braz J Urol       Date:  2015 Sep-Oct       Impact factor: 1.541

8.  MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial.

Authors:  Francesco Giganti; Caroline M Moore; Nicola L Robertson; Neil McCartan; Charles Jameson; Simon R J Bott; Mathias Winkler; Giulio Gambarota; Brandon Whitcher; Ramiro Castro; Mark Emberton; Clare Allen; Alex Kirkham
Journal:  Eur Radiol       Date:  2017-05-18       Impact factor: 5.315

9.  Undiagnosed prostatic malignancy at the time of radical cystoprostatectomy after prior prostatic radiation therapy.

Authors:  Pranav Sharma; Kamran Zargar-Shoshtari; Philippe E Spiess; Wade J Sexton; Michael A Poch
Journal:  Urol Ann       Date:  2016 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.